TriLink BioTechnologies
San Diego, CA
Reagent / Material Supplier
Program data pending ClinicalTrials.gov matching
· Last scored 2026-03-15
63.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
Quick Facts: TriLink BioTechnologies
- Signal Score
- 63.0/100 (as of 2026-03-15)
- Quality Compliance
- Assessment pending
- Headquarters
- San Diego, CA
- Modalities
- mRNA, Oligonucleotide
- Active CGT Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CGT manufacturing intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Oligonucleotide
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
68.0
Parent company: Maravai LifeSciences (MRVI)
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Subsidiary of Maravai LifeSciences
SEC FilingsParent: Maravai LifeSciences
Parent company: Maravai LifeSciences (MRVI)
Financial assessment: 68.0/100
Capacity
58.0
1 CGT manufacturing site: San Diego, CA
Modalities: mRNA, Oligonucleotide
Capacity assessment: 58.0/100
Sites: San Diego, CA
Source: SEC EDGAR, press monitoring, company profiles
1 CGT manufacturing site
Recent Press1 articles
1 CGT manufacturing site: San Diego, CA
Modalities: mRNA, Oligonucleotide
Capacity assessment: 58.0/100
Recent News 1 articles
4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer - News-Medical
4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer News-Medical
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: